Synopsys (NASDAQ:SNPS) Raised to Neutral at BNP Paribas Exane

Synopsys (NASDAQ:SNPS) was upgraded by equities researchers at BNP Paribas Exane from an “underperform” rating to a “neutral” rating in a research report issued to clients and investors on Thursday, Marketbeat Ratings reports. The firm currently has a $420.00 price target on the semiconductor company’s stock. BNP Paribas Exane’s price objective points to a potential upside of 1.68% from the company’s current price.

Other equities research analysts have also recently issued reports about the company. Bank of America boosted their price objective on Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, May 28th. Benchmark reiterated a “buy” rating and set a $570.00 target price on shares of Synopsys in a research note on Thursday, August 27th. Weiss Ratings lowered Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, September 11th. Mizuho lowered their price target on Synopsys from $600.00 to $550.00 and set an “outperform” rating for the company in a report on Thursday, August 27th. Finally, Needham & Company LLC restated a “buy” rating and set a $580.00 price target on shares of Synopsys in a research report on Thursday, August 27th. Thirteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $561.00.

Synopsys Stock Up 0.9%

SNPS opened at $413.06 on Thursday. Synopsys has a 12 month low of $362.55 and a 12 month high of $539.48. The stock has a market capitalization of $79.16 billion, a P/E ratio of 72.98, a P/E/G ratio of 2.24 and a beta of 1.23. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The business has a 50 day simple moving average of $399.91 and a 200-day simple moving average of $435.77.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same quarter in the prior year, the company posted $3.39 earnings per share. The company’s quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities analysts anticipate that Synopsys will post 10.97 earnings per share for the current fiscal year.

Insider Activity at Synopsys

In other Synopsys news, insider Aart de Geus sold 25,000 shares of the business’s stock in a transaction on Monday, August 31st. The stock was sold at an average price of $441.76, for a total value of $11,044,000.00. Following the completion of the transaction, the insider directly owned 120,421 shares in the company, valued at approximately $53,197,180.96. The trade was a 17.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,604 shares of the company’s stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total value of $5,474,747.52. Following the sale, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at $28,815,151.20. The trade was a 15.97% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 89,245 shares of company stock valued at $37,992,919. 0.56% of the stock is currently owned by company insiders.

Institutional Trading of Synopsys

A number of large investors have recently added to or reduced their stakes in SNPS. Sankala Group LLC purchased a new stake in Synopsys in the fourth quarter worth approximately $25,000. Elevation Wealth Partners LLC grew its stake in Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after buying an additional 27 shares during the last quarter. Osbon Capital Management LLC bought a new stake in shares of Synopsys in the 2nd quarter valued at $25,000. IMG Wealth Management Inc. bought a new position in shares of Synopsys in the second quarter worth about $28,000. Finally, Geneos Wealth Management Inc. raised its position in shares of Synopsys by 151.5% in the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after purchasing an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Company Profile

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and related services. Its products help semiconductor and electronics companies design, verify, test and manufacture integrated circuits and complex electronic systems.

The company’s EDA portfolio includes tools for digital and analog design, simulation, verification, physical implementation, signoff and manufacturing preparation. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, embedded memories and security-related components, which customers can incorporate into system-on-chip designs.

Synopsys additionally offers software integrity and application security solutions that help organizations identify and manage vulnerabilities and risks in the software development lifecycle.